<html>
<head>
<title>Utah Legislature HB0192</title>
</head>
<body>
<div id="content">
<font face="Arial">
</font><font face="Arial" size="3">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>OPIATE OVERDOSE RESPONSE ACT -- PILOT PROGRAM</b></center><br/>2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><center>AND OTHER AMENDMENTS</b></font><font face="Arial" size="2"></center><br/>3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>2016 GENERAL SESSION</center><br/>4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>STATE OF UTAH</center><br/>5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3"><b>Chief Sponsor:  Mike K. McKell</b></font><font face="Arial" size="2"></center><br/>6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3">Senate Sponsor:  </font><font face="Arial" size="2"></font><font face="Arial" size="3">____________</font><font face="Arial" size="2"></center><br/>7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>LONG TITLE</b><br/>9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>General Description:</b><br/>10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill renames the Emergency Administration of Opiate Antagonist Act as the<br/>11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Opiate Overdose Response Act, amends the act, and makes related amendments.<br/>12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Highlighted Provisions:</b><br/>13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill:<br/>14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;renames the Emergency Administration of Opiate Antagonist Act as the Opiate<br/>15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Overdose Response Act;<b></b><br/>16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;amends definitions;<br/>17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;amends liability provisions; <br/>18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;creates the Opiate Overdose Outreach Pilot Program within the Department of<br/>19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Health;<br/>20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;authorizes grants from the program;<br/>21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;specifies how grants may be used;<br/>22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;requires annual reporting by grantees;<br/>23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;requires rulemaking by the Department of Health;<br/>24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;requires annual reporting on the program by the Department of Health;<br/>25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;designates program funding as nonlapsing; and<br/>26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;makes technical changes. <br/>27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Money Appropriated in this Bill:</b><br/><hr>28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill appropriates:<br/>29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to Department of Health -- Disease Control and Prevention, as an ongoing<br/>30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;appropriation:<br/>31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;from the General Fund, $500,000, for the newly created Opiate Overdose<br/>32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Outreach Pilot Program;  and<br/>33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to Department of Health -- Disease Control and Prevention , as a one-time<br/>34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;appropriation:<br/>35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;from the General Fund, $500,000, for the newly created Opiate Overdose<br/>36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Outreach Pilot Program. <br/>37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Other Special Clauses:</b><br/>38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Utah Code Sections Affected:</b><br/>40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AMENDS:<br/>41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#26-55-101">26-55-101</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#26-55-102">26-55-102</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#26-55-104">26-55-104</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-17b-507">58-17b-507</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-31b-703">58-31b-703</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-67-702">58-67-702</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>47&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-68-702">58-68-702</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-70a-505">58-70a-505</a></b>, as enacted by Laws of Utah 2014, Chapter 130<br/>49&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#63j-1-602.1">63J-1-602.1</a></b>, as last amended by Laws of Utah 2015, Chapters 136 and 180<br/>50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ENACTS:<br/>51&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#26-55-105">26-55-105</a></b>, Utah Code Annotated 1953<br/>52&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>53&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Be it enacted by the Legislature of the state of Utah:</i><br/>54&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 1.  Section <b>26-55-101</b><a name="26-55-101"></a> is amended to read:<br/>55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>CHAPTER 55.  OPIATE OVERDOSE RESPONSE ACT</b></center><br/>56&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>26-55-101.</b>   <b>Title.</b><br/>57&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This chapter is known as the "[<strike>Emergency Administration of</strike>] Opiate [<strike>Antagonist</strike>]<br/>58&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Overdose Response</u> Act."<br/><hr>59&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 2.  Section <b>26-55-102</b><a name="26-55-102"></a> is amended to read:<br/>60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>26-55-102.</b>   <b>Definitions.</b><br/>61&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As used in this chapter:<br/>62&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  "Controlled substance" means the same as that term is defined in Title 58, Chapter</u><br/>63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>37, Utah Controlled Substances Act.</u><br/>64&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(1)</strike>] <u>(2)</u>  "Health care facility" means a hospital, a hospice inpatient residence, a<br/>65&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;nursing facility, a dialysis treatment facility, an assisted living residence, an entity that provides<br/>66&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;home- and community-based services, a hospice or home health care agency, or another facility<br/>67&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;that provides or contracts to provide health care services, which facility is licensed under<br/>68&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chapter 21, Health Care Facility Licensing and Inspection Act.<br/>69&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(2)</strike>] <u>(3)</u>  "Health care provider" means:<br/>70&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  a physician<u>,</u> as defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-67-102&session=2016GS">58-67-102</a>;<br/>71&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  an advanced practice registered nurse<u>,</u> as defined in Subsection <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-31b-102&session=2016GS">58-31b-102</a>(13); or<br/>72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  a physician assistant<u>,</u> as defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-70a-102&session=2016GS">58-70a-102</a>.<br/>73&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(4)  "Increased risk" means risk exceeding the risk typically experienced by an</u><br/>74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>individual who is not using, and is not likely to use, an opiate.</u><br/>75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(3)</strike>] <u>(5)</u>  "Opiate" [<strike>is</strike>] <u>means the same</u> as <u>that term is</u> defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37-2&session=2016GS">58-37-2</a>.<br/>76&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(4)</strike>] <u>(6)</u>  "Opiate antagonist"<u>:</u><br/>77&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)</u>  means naloxone hydrochloride or any similarly acting drug that is not a controlled<br/>78&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;substance and that is approved by the federal Food and Drug Administration for the treatment<br/>79&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of [<strike>a</strike>] <u>an opiate-related</u> drug overdose[<strike>.</strike>] <u>event; and</u><br/>80&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  includes paraphernalia required to administer the drug.</u><br/>81&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(5)</strike>] <u>(7)</u>  "Opiate-related drug overdose event" means an acute condition, including a<br/>82&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;decreased level of consciousness or respiratory depression resulting from the consumption or<br/>83&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;use of a controlled substance, or another substance with which a controlled substance was<br/>84&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;combined, and that a person would reasonably believe to require medical assistance.<br/>85&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 3.  Section <b>26-55-104</b><a name="26-55-104"></a> is amended to read:<br/>86&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>26-55-104.</b>   <b>Prescribing, dispensing, and administering an opiate antagonist --</b><br/>87&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Immunity from liability.</b><br/>88&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) (a) <u>(i)  For purposes of Subsection (1)(a)(ii), "a person other than a health care</u><br/>89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>facility or health care provider" includes a person described in Subsections <a href="#26-55-105">26-55-105</a>(1)(a)(i)</u><br/><hr>90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>through (1)(a)(iv).</u><br/>91&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)</u>  Except as provided in Subsection (1)(b), a person other than a health care facility or<br/>92&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;health care provider who acts in good faith to administer an opiate antagonist to [<strike>another</strike><br/>93&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>person</strike>] <u>an individual</u> whom the person believes to be [<strike>suffering</strike>] <u>experiencing</u> an opiate-related<br/>94&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;drug overdose event is not liable for any civil damages [<strike>or</strike>] <u>for</u> acts or omissions made as a<br/>95&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;result of administering the opiate antagonist.<br/>96&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  A health care provider:<br/>97&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  does not have immunity from liability under Subsection (1)(a) when the health care<br/>98&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provider is acting within the scope of the health care provider's responsibilities or duty of care;<br/>99&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and<br/>100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  does have immunity from liability under Subsection (1)(a) if the health care<br/>101&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provider is under no legal duty to respond and otherwise complies with Subsection (1)(a).<br/>102&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  Notwithstanding Sections <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-1-501&session=2016GS">58-1-501</a>, <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-501&session=2016GS">58-17b-501</a>, and <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-502&session=2016GS">58-17b-502</a>, a health care<br/>103&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provider who is licensed to prescribe [<strike>or dispense</strike>] an opiate antagonist may[<strike>, without a</strike><br/>104&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>prescriber-patient relationship,</strike>] prescribe or dispense an opiate antagonist [<strike>without liability for</strike><br/>105&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>any civil damages or acts or omissions made as a result of prescribing or dispensing an opiate</strike><br/>106&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>antagonist in good faith, to</strike>]:<br/>107&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>(i)  to</u> an individual who is at increased risk of experiencing [<strike>or who is likely to</strike><br/>108&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>experience</strike>] an opiate-related drug overdose event; or<br/>109&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(b)</strike>] <u>(ii)  to</u> a family member of, friend of, or other person<u>, including a person described</u><br/>110&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>in Subsections <a href="#26-55-105">26-55-105</a>(1)(a)(i) through (1)(a)(iv),</u> who [<strike>may be</strike>] <u>is</u> in a position to assist an<br/>111&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;individual who may be at increased risk of experiencing [<strike>or who is likely to experience</strike>] an<br/>112&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;opiate-related drug overdose event[<strike>.</strike>]<u>;</u><br/>113&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  without a prescriber-patient relationship; and</u><br/>114&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  without liability for any civil damages for acts or omissions made as a result of</u><br/>115&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>prescribing or dispensing the opiate antagonist in good faith.</u><br/>116&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  A [<strike>person</strike>] <u>health care provider</u> who [<strike>prescribes or</strike>] dispenses an opiate antagonist<br/>117&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>to an individual under Subsection (2)(a)</u> shall provide education to the individual [<strike>described in</strike><br/>118&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>Subsection (2)(a) or (b)</strike>] that includes [<strike>instructions to take the person who received</strike>]<br/>119&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>instruction:</u><br/>120&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  on the proper administration of the opiate antagonist; and</u><br/><hr>121&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  that the individual to whom the opiate antagonist is dispensed should ensure that</u><br/>122&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>the individual to whom</u> the opiate antagonist <u>is administered is taken</u> to an emergency care<br/>123&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;facility for a medical evaluation <u>immediately following administration of the opiate antagonist</u>.<br/>124&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 4.  Section <b>26-55-105</b><a name="26-55-105"></a> is enacted to read:<br/>125&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26-55-105.</u></b>  <b>Opiate Overdose Outreach Pilot Program -- Grants -- Annual</b><br/>126&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>reporting by grantees -- Rulemaking -- Annual reporting by department.</b><br/>127&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  For purposes of this section, "persons who may be in a position to assist an</u><br/>128&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>individual who is at increased risk of experiencing an opiate-related drug overdose event":</u><br/>129&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  means the following organizations:</u><br/>130&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  a law enforcement agency;</u><br/>131&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  an organization that provides drug or alcohol treatment services;</u><br/>132&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  an organization that provides services to the homeless;</u><br/>133&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iv)  an organization that provides training on the proper administration of an opiate</u><br/>134&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>antagonist in response to an opiate-related drug overdose event; or</u><br/>135&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(v)  except as provided in Subsection (1)(b), any other organization, as defined by</u><br/>136&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>department rule made under Subsection (7)(e), that may be in a position to assist an individual</u><br/>137&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>who is at increased risk of experiencing an opiate-related drug overdose event; and</u><br/>138&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  does not mean:</u><br/>139&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  a person licensed under Title 58, Chapter 17b, Pharmacy Practice Act;</u><br/>140&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  a health care facility; or</u><br/>141&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  an individual.</u><br/>142&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  There is created within the department the "Opiate Overdose Outreach Pilot</u><br/>143&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Program."</u><br/>144&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(3)  No later than September 1, 2016, and with available funding, the department shall</u><br/>145&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>grant funds through the program to persons who may be in a position to assist an individual</u><br/>146&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>who is at increased risk of experiencing an opiate-related drug overdose event.</u><br/>147&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(4)  Funds granted by the program:</u><br/>148&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  may be used by a grantee to:</u><br/>149&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  pay for the purchase by the grantee of an opiate antagonist; or</u><br/>150&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  pay for the grantee's cost of providing training on the proper administration of an</u><br/>151&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>opiate antagonist in response to an opiate-related drug overdose event; and</u><br/><hr>152&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  may not be used:</u><br/>153&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  to pay for costs associated with the storage or dispensing of an opiate antagonist; or</u><br/>154&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  for any other purposes.</u><br/>155&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(5)  Grantees shall report annually to the department on the use of granted funds in</u><br/>156&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>accordance with department rules made under Subsection (7)(d).</u><br/>157&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(6)  The department may not use funds appropriated to it for the program to pay for</u><br/>158&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>costs associated with administering the program.</u><br/>159&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(7)  No later than July 1, 2016, the department shall, in accordance with Title 63G,</u><br/>160&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Chapter 3, Utah Administrative Rulemaking Act, make rules specifying:</u><br/>161&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  how to apply for a grant from the program;</u><br/>162&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  the criteria used by the department to determine whether a grant request is</u><br/>163&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>approved, including criteria providing that:</u><br/>164&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  grants are awarded to areas of the state, including rural areas, that would benefit</u><br/>165&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>most from the grant; and</u><br/>166&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  no more than 15% of the total amount granted by the program is used to pay for</u><br/>167&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>grantees' costs of providing training on the proper administration of an opiate antagonist in</u><br/>168&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>response to an opiate-related drug overdose event;</u><br/>169&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  the criteria used by the department to determine the amount of a grant;</u><br/>170&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  the information a grantee shall report annually to the department under Subsection</u><br/>171&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(4), including:</u><br/>172&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  the amount of opiate antagonist purchased and dispensed by the grantee during the</u><br/>173&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>reporting period;</u><br/>174&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  the names of the individuals to whom the opiate antagonist was dispensed by the</u><br/>175&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>grantee;</u><br/>176&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  the number of lives known to have been saved during the reporting period as a</u><br/>177&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>result of opiate antagonist dispensed by the grantee; and</u><br/>178&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iv)  the manner in which the grantee shall record, preserve, and make available for</u><br/>179&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>audit by the department the information described in Subsections (7)(d)(i) through (7)(d)(iii);</u><br/>180&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>and</u><br/>181&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  as required by Subsection (1)(a)(v), any other organization that may be in a position</u><br/>182&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>to assist an individual who is at increased risk of experiencing an opiate-related drug overdose</u><br/><hr>183&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>event.</u><br/>184&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(8)  The department shall report to the Legislature's Social Services Appropriations</u><br/>185&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Subcommittee no later than September 1 of each year on the outcomes of the Opiate Overdose</u><br/>186&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Outreach Pilot Program.</u><br/>187&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 5.  Section <b>58-17b-507</b><a name="58-17b-507"></a> is amended to read:<br/>188&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-17b-507.</b>   <b>Opiate antagonist -- Immunity from liability -- Exclusion from</b><br/>189&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>unlawful or unprofessional conduct.</b><br/>190&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  As used in this section:</u><br/>191&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  "Opiate antagonist" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>192&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  "Opiate-related drug overdose event" means the same as that term is defined in</u><br/>193&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section <a href="#26-55-102">26-55-102</a>.</u><br/>194&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(1)</strike>] <u>(2)</u>  A person licensed under this chapter who dispenses an opiate antagonist [<strike>as</strike><br/>195&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>defined in Section <a href="#26-55-102">26-55-102</a></strike>] to an individual with a prescription for an opiate antagonist is<br/>196&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;not liable for any civil damages resulting from the outcomes that result from the eventual<br/>197&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;administration of the opiate antagonist to [<strike>a person</strike>] <u>an individual</u> who another [<strike>person</strike>]<br/>198&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>individual</u> believes is [<strike>suffering</strike>] <u>experiencing</u> an opiate-related drug overdose [<strike>as defined in</strike><br/>199&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>Section <a href="#26-55-102">26-55-102</a></strike>] <u>event</u>.<br/>200&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(2)</strike>] <u>(3)</u>  The provisions of this section <u>and Title 26, Chapter 55, Opiate Overdose</u><br/>201&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Response Act,</u> do not establish a duty or standard of care in the prescribing, dispensing, or<br/>202&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;administration of an opiate antagonist.<br/>203&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(3)</strike>] <u>(4)</u>  It is not unprofessional conduct or unlawful conduct for a licensee under this<br/>204&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;chapter to dispense an opiate antagonist to a person<u>, including a person described in</u><br/>205&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Subsections <a href="#26-55-105">26-55-105</a>(1)(a)(i) through (1)(a)(iv),</u> on behalf of [<strike>another person</strike>] <u>an individual</u> if<br/>206&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the person obtaining the opiate antagonist has a prescription for the opiate antagonist from a<br/>207&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;licensed prescriber.<br/>208&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 6.  Section <b>58-31b-703</b><a name="58-31b-703"></a> is amended to read:<br/>209&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-31b-703.</b>   <b>Opiate antagonist -- Exclusion from unprofessional or unlawful</b><br/>210&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>conduct.</b><br/>211&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(1)  Title 26, Chapter 55, Emergency Administration of Opiate Antagonist Act, applies</strike><br/>212&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>to a licensee under this chapter.</strike>]<br/>213&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  As used in this section:</u><br/><hr>214&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  "Dispensing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>215&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  "Increased risk" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>216&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  "Opiate antagonist" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>217&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  "Opiate-related drug overdose event" means the same as that term is defined in</u><br/>218&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section <a href="#26-55-102">26-55-102</a>.</u><br/>219&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  "Prescribing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>220&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  The prescribing or dispensing of an opiate antagonist [<strike>as defined in Section</strike><br/>221&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike><a href="#26-55-102">26-55-102</a></strike>] by a licensee under this chapter is not unprofessional or unlawful conduct if the<br/>222&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;licensee prescribed or dispensed the opiate antagonist in a good faith effort to assist:<br/>223&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  [<strike>a person</strike>] <u>an individual</u> who is at increased risk of experiencing [<strike>or who is likely to</strike><br/>224&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>experience</strike>] an opiate-related drug overdose event [<strike>as defined in Section <a href="#26-55-102">26-55-102</a></strike>]; or<br/>225&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  a family member of, friend of, or other person<u>, including a person described in</u><br/>226&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Subsections <a href="#26-55-105">26-55-105</a>(1)(a)(i) through (1)(a)(iv),</u> who is in a position to assist [<strike>a person</strike>] <u>an</u><br/>227&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>individual</u> who [<strike>may be</strike>] <u>is</u> at increased risk of experiencing [<strike>or who is likely to experience</strike>] an<br/>228&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;opiate-related drug overdose event.<br/>229&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  The provisions of this section and Title 26, Chapter 55, [<strike>Emergency Administration</strike><br/>230&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>of</strike>] Opiate [<strike>Antagonist</strike>] <u>Overdose Response</u> Act, do not establish a duty or standard of care in<br/>231&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the prescribing, dispensing, or administration of an opiate antagonist.<br/>232&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 7.  Section <b>58-67-702</b><a name="58-67-702"></a> is amended to read:<br/>233&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-67-702.</b>   <b>Opiate antagonist -- Exclusion from unlawful or unprofessional</b><br/>234&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>conduct.</b><br/>235&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(1)  Title 26, Chapter 55, Emergency Administration of Opiate Antagonist Act, applies</strike><br/>236&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>to a licensee under this chapter.</strike>]<br/>237&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  As used in this section:</u><br/>238&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  "Dispensing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>239&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  "Increased risk" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>240&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  "Opiate antagonist" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>241&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  "Opiate-related drug overdose event" means the same as that term is defined in</u><br/>242&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section <a href="#26-55-102">26-55-102</a>.</u><br/>243&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  "Prescribing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>244&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  The prescribing or dispensing of an opiate antagonist [<strike>as defined in Section</strike><br/><hr>245&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike><a href="#26-55-102">26-55-102</a></strike>] by a licensee under this chapter is not unprofessional or unlawful conduct if the<br/>246&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;licensee prescribed or dispensed the opiate antagonist in a good faith effort to assist:<br/>247&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  [<strike>a person</strike>] <u>an individual</u> who is at increased risk of experiencing [<strike>or who is likely to</strike><br/>248&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>experience</strike>] an opiate-related drug overdose event [<strike>as defined in Section <a href="#26-55-102">26-55-102</a></strike>]; or<br/>249&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  a family member of, friend of, or other person<u>, including a person described in</u><br/>250&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Subsections <a href="#26-55-105">26-55-105</a>(1)(a)(i) through (1)(a)(iv),</u> who is in a position to assist [<strike>a person</strike>] <u>an</u><br/>251&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>individual</u> who [<strike>may be</strike>] <u>is</u> at increased risk of experiencing [<strike>or who is likely to experience</strike>] an<br/>252&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;opiate-related drug overdose event.<br/>253&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  The provisions of this section and Title 26, Chapter 55, [<strike>Emergency Administration</strike><br/>254&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>of</strike>] Opiate [<strike>Antagonist</strike>] <u>Overdose Response</u> Act, do not establish a duty or standard of care in<br/>255&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the prescribing, dispensing, or administration of an opiate antagonist.<br/>256&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 8.  Section <b>58-68-702</b><a name="58-68-702"></a> is amended to read:<br/>257&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-68-702.</b>   <b>Opiate antagonist -- Exclusion from unlawful or unprofessional</b><br/>258&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>conduct.</b><br/>259&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(1)  Title 26, Chapter 55, Emergency Administration of Opiate Antagonist Act, applies</strike><br/>260&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>to a licensee under this chapter.</strike>]<br/>261&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  As used in this section:</u><br/>262&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  "Dispensing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>263&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  "Increased risk" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>264&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  "Opiate antagonist" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>265&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  "Opiate-related drug overdose event" means the same as that term is defined in</u><br/>266&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section <a href="#26-55-102">26-55-102</a>.</u><br/>267&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  "Prescribing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>268&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  The prescribing or dispensing of an opiate antagonist [<strike>as defined in Section</strike><br/>269&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike><a href="#26-55-102">26-55-102</a></strike>] by a licensee under this chapter is not unprofessional or unlawful conduct if the<br/>270&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;licensee prescribed or dispensed the opiate antagonist in a good faith effort to assist:<br/>271&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  [<strike>a person</strike>] <u>an individual</u> who is at increased risk of experiencing [<strike>or who is likely to</strike><br/>272&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>experience</strike>] an opiate-related drug overdose event [<strike>as defined in Section <a href="#26-55-102">26-55-102</a></strike>]; or<br/>273&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  a family member of, friend of, or other person<u>, including a person described in</u><br/>274&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Subsections <a href="#26-55-105">26-55-105</a>(1)(a)(i) through (1)(a)(iv),</u> who is in a position to assist [<strike>a person</strike>] <u>an</u><br/>275&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>individual</u> who [<strike>may be</strike>] <u>is</u> at increased risk of experiencing [<strike>or who is likely to experience</strike>] an<br/><hr>276&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;opiate-related drug overdose event.<br/>277&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  The provisions of this section and Title 26, Chapter 55, [<strike>Emergency Administration</strike><br/>278&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>of</strike>] Opiate [<strike>Antagonist</strike>] <u>Overdose Response</u> Act, do not establish a duty or standard of care in<br/>279&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the prescribing, dispensing, or administration of an opiate antagonist.<br/>280&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 9.  Section <b>58-70a-505</b><a name="58-70a-505"></a> is amended to read:<br/>281&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-70a-505.</b>   <b>Opiate antagonist -- Exclusion from unlawful or unprofessional</b><br/>282&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>conduct.</b><br/>283&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(1)  Title 26, Chapter 55, Emergency Administration of Opiate Antagonist Act, applies</strike><br/>284&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>to a licensee under this chapter.</strike>]<br/>285&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  As used in this section:</u><br/>286&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  "Dispensing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>287&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  "Increased risk" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>288&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  "Opiate antagonist" means the same as that term is defined in Section <a href="#26-55-102">26-55-102</a>.</u><br/>289&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  "Opiate-related drug overdose event" means the same as that term is defined in</u><br/>290&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section <a href="#26-55-102">26-55-102</a>.</u><br/>291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  "Prescribing" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2016GS">58-17b-102</a>.</u><br/>292&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  The prescribing or dispensing of an opiate antagonist [<strike>as defined in Section</strike><br/>293&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike><a href="#26-55-102">26-55-102</a></strike>] by a licensee under this chapter is not unprofessional or unlawful conduct if the<br/>294&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;licensee prescribed or dispensed the opiate antagonist in a good faith effort to assist:<br/>295&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  [<strike>a person</strike>] <u>an individual</u> who is at increased risk of experiencing [<strike>or who is likely to</strike><br/>296&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>experience</strike>] an opiate-related drug overdose event [<strike>as defined in Section <a href="#26-55-102">26-55-102</a></strike>]; or<br/>297&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  a family member of, friend of, or other person<u>, including a person described in</u><br/>298&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Subsections <a href="#26-55-105">26-55-105</a>(1)(a)(i) through (1)(a)(iv),</u> who is in a position to assist [<strike>a person</strike>] <u>an</u><br/>299&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>individual</u> who [<strike>may be</strike>] <u>is</u> at increased risk of experiencing [<strike>or who is likely to experience</strike>] an<br/>300&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;opiate-related drug overdose event.<br/>301&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  The provisions of this section and Title 26, Chapter 55, [<strike>Emergency Administration</strike><br/>302&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>of</strike>] Opiate [<strike>Antagonist</strike>] <u>Overdose Response</u> Act, do not establish a duty or standard of care in<br/>303&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the prescribing, dispensing, or administration of an opiate antagonist.<br/>304&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 10.  Section <b>63J-1-602.1</b><a name="63j-1-602.1"></a> is amended to read:<br/>305&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>63J-1-602.1.</b>   <b>List of nonlapsing accounts and funds -- General authority and Title</b><br/>306&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>1 through Title 30.</b><br/><hr>307&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)  Appropriations made to the Legislature and its committees.<br/>308&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  The Percent-for-Art Program created in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=9-6-404&session=2016GS">9-6-404</a>.<br/>309&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  The Martin Luther King, Jr. Civil Rights Support Restricted Account created in<br/>310&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=9-18-102&session=2016GS">9-18-102</a>.<br/>311&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)  The LeRay McAllister Critical Land Conservation Program created in Section<br/>312&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=11-38-301&session=2016GS">11-38-301</a>.<br/>313&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)  An appropriation made to the Division of Wildlife Resources for the appraisal and<br/>314&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;purchase of lands under the Pelican Management Act, as provided in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=23-21a-6&session=2016GS">23-21a-6</a>.<br/>315&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)  Award money under the State Asset Forfeiture Grant Program, as provided under<br/>316&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=24-4-117&session=2016GS">24-4-117</a>.<br/>317&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)  Funds collected from the program fund for local health department expenses<br/>318&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;incurred in responding to a local health emergency under Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-1-38&session=2016GS">26-1-38</a>.<br/>319&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)  Funds collected from the emergency medical services grant program, as provided in<br/>320&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-8a-207&session=2016GS">26-8a-207</a>.<br/>321&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9)  The Prostate Cancer Support Restricted Account created in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-21a-303&session=2016GS">26-21a-303</a>.<br/>322&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(10)  State funds appropriated for matching federal funds in the Children's Health<br/>323&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance Program as provided in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-40-108&session=2016GS">26-40-108</a>.<br/>324&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(11)  The Utah Health Care Workforce Financial Assistance Program created in Section<br/>325&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-46-102&session=2016GS">26-46-102</a>.<br/>326&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(12)  The primary care grant program created in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-10b-102&session=2016GS">26-10b-102</a>.<br/>327&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(13)  The Rural Physician Loan Repayment Program created in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-46a-103&session=2016GS">26-46a-103</a>.<br/>328&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(14)  The Opiate Overdose Outreach Pilot Program created in Section <a href="#26-55-105">26-55-105</a>.</u><br/>329&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 11.  <b>Appropriation.</b><br/>330&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Under the terms and conditions of Title 63J, Chapter 1, Budgetary Procedures Act, for</u><br/>331&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>the fiscal year beginning July 1, 2016, and ending June 30, 2017, the following sums of money</u><br/>332&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>are appropriated from resources not otherwise appropriated, or reduced from amounts</u><br/>333&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>previously appropriated, out of the funds or amounts indicated.  These sums of money are in</u><br/>334&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>addition to amounts previously appropriated for fiscal year 2017.</u><br/>335&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Item 1.  To Department of Health - Disease Control and Prevention</u><br/>336&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>From General Fund<div align="right">$500,000</u></div><br/>337&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule of Programs:</u><br/><hr>338&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Opiate Overdose Outreach Pilot Program&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$500,000</u><br/>339&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Item 2.  To Department of Health - Disease Control and Prevention</u><br/>340&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>From General Fund, One-time<div align="right">$500,000</u></div><br/>341&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule of Programs:</u><br/>342&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Opiate Overdose Outreach Pilot Program&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$500,000</u><br/><br/><hr style="width:90%; color: #333; text-align: right" /><br/><hr style="width:90%; color: #333; text-align: right" /><br/><br/><b>Legislative Review Note<br/>Office of Legislative Research and General Counsel</b>
</font>
</div>
</body>
</html>
